{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"citrullinemia-type-ii-adult-onset","columns":[{"gene":"","key":"population-a686e20391a36e1a3068","label":"Citrullinemia, type II, adult-onset","mondoId":"MONDO:0011326","onsetQualifier":null,"originColumnKey":"MONDO:0011326/OMIM:603471","originalViews":[{"key":"MONDO:0011326/OMIM:603471","label":"Citrullinemia, type II, adult-onset","scopeLabel":"OMIM:603471","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["046bbdb65a490b5ffe590b7d6781b69b9d0d2fa77e510003a704bfd5b9b4f688","2e083458eb151dd8465afcf2cd64d8a401a5f94a263658a60a3899685e41a5d9","45852bbe5a7103baf863bc362f62c37a8c2eb35288e21a617eaa6de82145b16e","460c981256f8410918e73f9f39fe46f51a76711c2ff57e4191186d3993f3ec92","57033504d9ed73ff07b02e4f9933904e9e99dd5092b85bc3ce03bea01a107f29","707a2f4ed058c6cf47cffa93f643817fab627b13624b2313fca982a4062d405a","7ccfb67ef617fe237ce6f64d7590a8f5fd07c22299a712e05f765babe6e34ddb","7ed9cb2303d8dec92f7116244b5f2d9671545c36e9a7c8cdc54e308dc2b0220a","889d254ea17edbdaca643207b7c0cab38c0c95ce1cd9cf2a1d4e648d58df9e78","90fad8b2651d7da3014697da4b515b0dde1cc34bc89c12ae5fbf02f7c6952e4a","997e097308dccee9f91b31c0378c0486bf9ac4053e9993c10a3cbda3ccd6ab8b","a763efbcfd327fff398ff887e543b89482a8a52355e054254484f00e7c02b76c","b970c8439d1ad72338331435f2b0cb5aa73c64791782f7bb178cb2b7b27f6e98","cea5a9e332c7d6b8ae2de260a346314e4e5821b218249c4691dee43a5da9da31","d3141ff98d4ad390bf3ce29adb481f0b73cb47630b9e3a1704f5bfd25541d415","eecbb5fa60974ab0ef76c1800078e6378698057e9e258c86e5883f965f95ac4b","fde8156294fdb0b9ccd4bd2b2be4ee5a0e92fe7b2779bfbba3bad7234f126a13"],"recordQualifiers":{},"scopeLabel":"OMIM:603471","sourceIds":["OMIM:603471"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a686e20391a36e1a3068"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0025630","HP:0033193","HP:0002181","HP:0001259","HP:0001289","HP:0031964","HP:0030948"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":12,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"published":17}},"features":[{"hpoId":"HP:0025630","label":"Argininosuccinic aciduria","primary":true},{"hpoId":"HP:0033193","label":"Ballooning hepatocyte degeneration","primary":true},{"hpoId":"HP:0002181","label":"Cerebral edema","primary":true},{"hpoId":"HP:0001259","label":"Coma","primary":true},{"hpoId":"HP:0001289","label":"Confusion","primary":true},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":true},{"hpoId":"HP:0030948","label":"Elevated gamma-glutamyltransferase level","primary":true},{"hpoId":"HP:0011966","label":"Elevated plasma citrulline","primary":false},{"hpoId":"HP:0001395","label":"Hepatic fibrosis","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0001402","label":"Hepatocellular carcinoma","primary":false},{"hpoId":"HP:0001987","label":"Hyperammonemia","primary":false},{"hpoId":"HP:0500153","label":"Hyperargininemia","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0001733","label":"Pancreatitis","primary":false},{"hpoId":"HP:0033196","label":"Portal inflammation","primary":false},{"hpoId":"HP:6000785","label":"Protein craving","primary":false}],"ledeHtml":"Adult-onset citrullinemia type II is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. The condition chiefly affects the nervous system, causing confusion, restlessness, memory loss, abnormal behaviors (such as aggression, irritability, and hyperactivity), seizures, and coma. These signs and symptoms can be life-threatening. The signs and symptoms appear during adulthood and are triggered by certain medications, infections, surgery, and alcohol intake.The features of adult-onset type II citrullinemia may also develop in people who as infants had a liver disorder called neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). In many cases, the signs and symptoms of NICCD resolve within a year. Years or even decades later, however, some of these people develop the characteristic features of adult-onset type II citrullinemia.adult-onset citrullinemia type II is caused by mutations in the SLC25A13 gene. This condition is inherited in an autosomal recessive pattern.","mondoId":"MONDO:0011326","node":{"canonicalSlug":"citrullinemia-type-ii-adult-onset","comparisons":[{"documentSha256":"138b2b1d801f46d6c2fa721573216956639c3bc56c7e20bbdadc980a86391bcf","key":"legacy-citrullinemia","kind":"legacy","label":"citrullinemia","memberIds":["MONDO:0008988","MONDO:0011326","MONDO:0011601","MONDO:0015991","MONDO:0016603"],"mondoId":"MONDO:0015991","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/citrullinemia.138b2b1d801f46d6c2fa721573216956639c3bc56c7e20bbdadc980a86391bcf.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"citrullinemia, type II, adult-onset","paragraphs":["Adult-onset citrullinemia type II is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. The condition chiefly affects the nervous system, causing confusion, restlessness, memory loss, abnormal behaviors (such as aggression, irritability, and hyperactivity), seizures, and coma. These signs and symptoms can be life-threatening. The signs and symptoms appear during adulthood and are triggered by certain medications, infections, surgery, and alcohol intake.The features of adult-onset type II citrullinemia may also develop in people who as infants had a liver disorder called neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). In many cases, the signs and symptoms of NICCD resolve within a year. Years or even decades later, however, some of these people develop the characteristic features of adult-onset type II citrullinemia.adult-onset citrullinemia type II is caused by mutations in the SLC25A13 gene. This condition is inherited in an autosomal recessive pattern."],"scope":"exact","source":"MONDO","upstream":"GARD:0010215","url":"https://monarchinitiative.org/MONDO:0011326"},"ownColumnKeys":["population-a686e20391a36e1a3068"],"publication":"published","relationships":[{"kind":"parent","label":"citrullinemia type II","mondoId":"MONDO:0016603","slug":"citrullinemia-type-ii"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24789"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"046bbdb65a490b5ffe590b7d6781b69b9d0d2fa77e510003a704bfd5b9b4f688","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"6/14","hpo_id":"HP:0033196","is_excluded":false,"label":"Portal inflammation","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2e083458eb151dd8465afcf2cd64d8a401a5f94a263658a60a3899685e41a5d9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"17/19","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"45852bbe5a7103baf863bc362f62c37a8c2eb35288e21a617eaa6de82145b16e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"14/19","hpo_id":"HP:0001987","is_excluded":false,"label":"Hyperammonemia","onset_id":null,"reference":"PMID:18620775","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"460c981256f8410918e73f9f39fe46f51a76711c2ff57e4191186d3993f3ec92","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"4/14","hpo_id":"HP:0033193","is_excluded":false,"label":"Ballooning hepatocyte degeneration","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"57033504d9ed73ff07b02e4f9933904e9e99dd5092b85bc3ce03bea01a107f29","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"5/19","hpo_id":"HP:0001733","is_excluded":false,"label":"Pancreatitis","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"707a2f4ed058c6cf47cffa93f643817fab627b13624b2313fca982a4062d405a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0500153","is_excluded":false,"label":"Hyperargininemia","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7ccfb67ef617fe237ce6f64d7590a8f5fd07c22299a712e05f765babe6e34ddb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"17/19","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"PMID:18620775","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7ed9cb2303d8dec92f7116244b5f2d9671545c36e9a7c8cdc54e308dc2b0220a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002181","is_excluded":false,"label":"Cerebral edema","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"889d254ea17edbdaca643207b7c0cab38c0c95ce1cd9cf2a1d4e648d58df9e78","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"11/14","hpo_id":"HP:0001395","is_excluded":false,"label":"Hepatic fibrosis","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"90fad8b2651d7da3014697da4b515b0dde1cc34bc89c12ae5fbf02f7c6952e4a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"1/19","hpo_id":"HP:0001402","is_excluded":false,"label":"Hepatocellular carcinoma","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"997e097308dccee9f91b31c0378c0486bf9ac4053e9993c10a3cbda3ccd6ab8b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"37/37","hpo_id":"HP:0011966","is_excluded":false,"label":"Elevated plasma citrulline","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a763efbcfd327fff398ff887e543b89482a8a52355e054254484f00e7c02b76c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"3/19","hpo_id":"HP:0001259","is_excluded":false,"label":"Coma","onset_id":null,"reference":"PMID:18620775","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b970c8439d1ad72338331435f2b0cb5aa73c64791782f7bb178cb2b7b27f6e98","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6000785","is_excluded":false,"label":"Protein craving","onset_id":null,"reference":"PMID:18620775","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cea5a9e332c7d6b8ae2de260a346314e4e5821b218249c4691dee43a5da9da31","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"15/19","hpo_id":"HP:0030948","is_excluded":false,"label":"Elevated gamma-glutamyltransferase level","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d3141ff98d4ad390bf3ce29adb481f0b73cb47630b9e3a1704f5bfd25541d415","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":"5/19","hpo_id":"HP:0001289","is_excluded":false,"label":"Confusion","onset_id":null,"reference":"PMID:18620775","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"eecbb5fa60974ab0ef76c1800078e6378698057e9e258c86e5883f965f95ac4b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0025630","is_excluded":false,"label":"Argininosuccinic aciduria","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"fde8156294fdb0b9ccd4bd2b2be4ee5a0e92fe7b2779bfbba3bad7234f126a13","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:603471","disease_name":"Citrullinemia, type II, adult-onset","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"PMID:10369257","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011326\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>GARD:0010215</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Adult-onset citrullinemia type II is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. The condition chiefly affects the nervous system, causing confusion, restlessness, memory loss, abnormal behaviors (such as aggression, irritability, and hyperactivity), seizures, and coma. These signs and symptoms can be life-threatening. The signs and symptoms appear during adulthood and are triggered by certain medications, infections, surgery, and alcohol intake.The features of adult-onset type II citrullinemia may also develop in people who as infants had a liver disorder called neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). In many cases, the signs and symptoms of NICCD resolve within a year. Years or even decades later, however, some of these people develop the characteristic features of adult-onset type II citrullinemia.adult-onset citrullinemia type II is caused by mutations in the SLC25A13 gene. This condition is inherited in an autosomal recessive pattern.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011326\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"citrullinemia-type-ii-adult-onset","sourceDocuments":[{"name":"MONDO: citrullinemia, type II, adult-onset","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011326"}],"sourceNote":"","synonyms":["adult-onset citrullinemia type 2","adult-onset citrullinemia type II","citrin deficiency","citrullinemia type 2","citrullinemia type II","citrullinemia, adult-onset type II","citrullinemia, type II, adult-onset","CTLN2"],"takeawayHtml":"","title":"citrullinemia, type II, adult-onset"},"schemaVersion":1}
